Leidos Holdings, Inc.
For the period ended Oct 3, 2025. Filed Nov 4, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Oct 3, 2025 · Filed Nov 4, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
RULE 10B5-1 TRADING ARRANGEMENT
The following table includes the material terms of each trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1 (c) under the Securities Exchange Act of 1934, as amended ("Rule 10b5-1 Plan") by our executive officers and directors during the three months ended October 3, 2025.
| Name and title | Date of adoption(1) | Date of termination | Scheduled expiration date(2) | Aggregate number of shares of common stock to be purchased or sold(3) |
|---|---|---|---|---|
| Elizabeth M. Porter, President Health & Civil | September 12, 2025 | N/A | April 8, 2026 | Up to 8,000 shares |
(1) Transactions under each Rule 10b5-1 Plan commence no earlier than 90 days after adoption, or such later date as required by Rule 10b5-1.
(2) Each Rule 10b5-1 Plan may expire on such earlier date as all transactions are completed.
(3) Each Rule 10b5-1 Plan provides for shares to be sold on multiple predetermined dates.
| Leidos Holdings, Inc. | 33 |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.